about
Community differentiation of the cutaneous microbiota in psoriasisExternal validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets.Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approachAn epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysisCritical review of prostate cancer predictive toolsDevelopment of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer.Initial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing.Guideline for referral of patients with suspected prostate cancer by family physicians and other primary care providers.Systematic review of clinical features of suspected prostate cancer in primary care.Pre-operative prediction of advanced prostatic cancer using clinical decision support systems: accuracy comparison between support vector machine and artificial neural network.Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.Prostate cancer risk prediction in a urology clinic in Mexico.The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community settingNomograms for colorectal cancer: A systematic reviewSelective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for GlioblastomaTumor markers in prostate cancer I: blood-based markers.Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population.Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancerBiomarkers in prostate cancer surveillance and screening: past, present, and future.Screening for prostate cancer: an update.Trends in prostate biopsy in Ontario, 1992-2014: a cohort study.Risk-based prostate cancer screening.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Risk stratification in prostate cancer screening.Risk-based prostate cancer screening: who and how?The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy.Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.Role of mpMRI of the prostate in screening for prostate cancer.Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.Improvement of severe baseline lower urinary tract symptoms following robotic-assisted laparoscopic prostatectomy.Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).Prostate cancer screening: and yet it moves!Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examination.Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy.Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
P2860
Q21195810-3FCB3B8C-5F31-4173-BE69-BB7555F37203Q33410362-E04DADC9-1C18-4C51-8663-CE46D31A98CAQ33770342-142FBBD5-87F4-472F-BC74-32E73C166B6CQ34071472-08F37088-F3F2-49EF-BF31-DC4668AB103DQ34104562-CA3EC00D-B430-4D45-B353-F39EC0C6B142Q34406622-4BFA8132-A425-4A4E-9AB8-3DF12CD009D9Q34451940-1015CCEC-C196-4A63-BAAB-66A693284647Q34994782-70D844C8-1C35-495E-A878-B5074E0059CBQ34994815-947B46A7-32F4-49F5-B2AA-8E03961B6A7FQ35201725-09C804C9-72CA-4D27-A83E-32AFAA763C2EQ35771276-BC8F44DB-680A-4BA6-908B-1892CB261527Q35996067-82A7646D-BEA3-4250-ADDE-BC28AFA9D612Q36185925-EE514336-BA3B-454D-AECC-596330D045F7Q36245607-2A8DEC2D-D7C9-41FC-B099-9595DEF3010DQ36421154-EDC09F7C-C41B-4E4F-95A7-41F86267BDE8Q36470507-D4742937-7E3C-4996-9BC4-C265AFA7E8E8Q36607766-D171E34A-A368-4100-8067-D90A287F6601Q36914829-3E1DFD74-32CE-4437-9D32-2B72083B19FDQ36928846-86754ABE-22BC-4CA1-AA3F-1321B5A29F0EQ37300931-72269D6A-0DEE-4AE1-A1D7-7EC1D32954D4Q37338478-2893049E-15B4-4327-BD05-931897087548Q37521017-8148744A-0338-4C8C-A85E-F4289F1FDA7AQ37963657-5D62E44C-F220-406B-B810-C800D9E673F0Q37972706-47A868B4-EAD9-40A8-BA10-3B797B576258Q38068114-B4F92628-64A9-47E5-8967-803726001D81Q38093463-3697DC93-9EC3-412F-A317-F59D141ADE3AQ38165242-3A5A0D0D-4FEE-43F9-9D8B-162787849B1CQ38268839-01AF6713-79A7-4BB5-9418-974C1D61CEEDQ38671170-3620F08E-3F89-42CF-A790-988F799EEEBDQ38913913-8C2E54A8-DE75-45A7-AC52-C34B2F48474CQ38943718-2DB91CDA-0F0B-4615-93D8-DEF1C6BD4DE1Q39023692-9E0243DB-9B25-4E30-B250-F0BC819AD0B5Q39069315-99BB1E03-8F4D-48D5-9B3B-02E835CB00A1Q39845544-365CBC83-0FB3-41B4-A8F1-A4417EA4D2C1Q40010533-E75E5D7D-5C48-4901-94A1-558255801DEEQ40014386-D6499A45-993D-4EEB-A2F5-D14012CBC6B6Q40037072-F7BF86E0-1F56-4383-A4F1-871E26E0D97FQ40100129-B8C12E68-04DA-4148-B0AF-D9ED0B7CC7C9Q40149911-3F20B941-569F-438E-8216-CC75701E2A71Q40181136-CC0A6040-A931-4CB5-881D-333FBF9AB3E3
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Assessing individual risk for prostate cancer.
@en
Assessing individual risk for prostate cancer.
@nl
type
label
Assessing individual risk for prostate cancer.
@en
Assessing individual risk for prostate cancer.
@nl
prefLabel
Assessing individual risk for prostate cancer.
@en
Assessing individual risk for prostate cancer.
@nl
P2093
P356
P1476
Assessing individual risk for prostate cancer.
@en
P2093
D Andrew Loblaw
John Trachtenberg
Laurence H Klotz
Linda Sugar
Michael A S Jewett
Michael W Kattan
Robert K Nam
P304
P356
10.1200/JCO.2007.10.6450
P407
P577
2007-08-01T00:00:00Z